Gennex Lab.

{
  "main_header": {
    "sid": 930938,
    "name": "Gennex Lab.",
    "stock_name": "Gennex Lab.",
    "full_name": "Gennex Laboratories Ltd",
    "name_url": "stocks-analysis/gennex-lab",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 0,
    "country_id": 34,
    "currency": "INR",
    "cmp": "9.99",
    "chg": -0.12,
    "chgp": "-1.19%",
    "dir": -1,
    "prev_price": "10.11",
    "mcapval": "246.00 Cr",
    "mcap": "Micro Cap",
    "scripcode": 531739,
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE509C01026",
    "curr_date": "Apr 30",
    "curr_time": "",
    "bse_nse_vol": "2.76 lacs",
    "exc_status": "Active",
    "traded_date": "Apr 30, 2026",
    "traded_date_str": "2026 04 30",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/gennex-lab-930938-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Gennex Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/gennex-laboratories-ltd-is-rated-sell-3963193",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/GennexLaborator_mojoScore_3963193.png",
        "date": "2026-04-26 10:10:02",
        "description": "Gennex Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 April 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Gennex Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/gennex-laboratories-ltd-is-rated-sell-3947415",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/GennexLaborator_mojoScore_3947415.png",
        "date": "2026-04-15 10:10:03",
        "description": "Gennex Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance."
      },
      {
        "title": "Gennex Laboratories Ltd: Valuation Shift Enhances Price Attractiveness Amid Mixed Returns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gennex-laboratories-ltd-valuation-shift-enhances-price-attractiveness-amid-mixed-returns-3933679",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/GennexLaborator_valuationdot_3933679.png",
        "date": "2026-04-06 08:01:15",
        "description": "Gennex Laboratories Ltd has witnessed a notable improvement in its valuation parameters, shifting from very attractive to attractive territory, driven primarily by a subdued price-to-earnings (P/E) ratio and price-to-book value (P/BV) metrics. Despite this positive valuation shift, the company’s stock performance over recent months and years presents a mixed picture when compared to broader market benchmarks such as the Sensex."
      },
      {
        "title": "Gennex Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/gennex-laboratories-ltd-is-rated-sell-3933050",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/GennexLaborator_mojoScore_3933050.png",
        "date": "2026-04-04 10:10:02",
        "description": "Gennex Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 April 2026, providing investors with the latest insights into its performance and outlook."
      },
      {
        "title": "Five Consecutive Losses Push Gennex Laboratories Ltd to a New 52-Week Low",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gennex-laboratories-ltd-stock-hits-52-week-low-amid-continued-downtrend-3925272",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/GennexLaborator_priceRelatedfactors_3925272.png",
        "date": "2026-03-30 14:21:21",
        "description": ""
      },
      {
        "title": "Five Consecutive Losses Push Gennex Laboratories Ltd to a New 52-Week Low",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gennex-laboratories-ltd-stock-hits-52-week-low-amid-market-downturn-3920358",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/GennexLaborator_priceRelatedfactors_3920358.png",
        "date": "2026-03-27 15:57:46",
        "description": ""
      },
      {
        "title": "Markets Rally, But Gennex Laboratories Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gennex-laboratories-ltd-stock-falls-to-52-week-low-of-rs806-3916038",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/GennexLaborator_priceRelatedfactors_3916038.png",
        "date": "2026-03-25 10:48:35",
        "description": "Despite a broad market upswing, Gennex Laboratories Ltd has slipped to a fresh 52-week low of Rs 8.06 on 25 Mar 2026, marking a near 53% decline from its 52-week high of Rs 17.25. This divergence from the market rally highlights persistent headwinds for the micro-cap pharmaceutical player."
      },
      {
        "title": "Gennex Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/gennex-laboratories-ltd-is-rated-sell-3909891",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/GennexLaborator_mojoScore_3909891.png",
        "date": "2026-03-24 10:10:02",
        "description": "Gennex Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 24 March 2026, providing investors with the latest insights into the company’s performance and outlook."
      },
      {
        "title": "Markets Rally, But Gennex Laboratories Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/gennex-laboratories-ltd-stock-hits-52-week-low-at-rs83-amid-sector-and-market-downturn-3907844",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/GennexLaborator_priceRelatedfactors_3907844.png",
        "date": "2026-03-23 12:36:11",
        "description": ""
      }
    ],
    "total": 163,
    "sid": "930938",
    "stock_news_url": "https://www.marketsmojo.com/news/gennex-laboratories-930938"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "21-Apr-2026",
      "details": "Pursuant to Regulation 47 of SEBI of SEBI (LODR) Regulations 2015 please find enclosed herewith Newspaper Publication of EGM Notice and eVoting related instructions advertisement published in Business Standard and Saksham (Local-Telugu) on April 21 2026 for the Extraordinary General Meeting of the Company to be held on May 12 2026. We request you to take the above information on record and acknowledge receipt of the same.",
      "source": "BSE"
    },
    {
      "caption": "Notice Convening Extraordinary General Meeting (EGM) To Be Held On Tuesday May 12 2026 Through VC And OAVM",
      "datetime": "20-Apr-2026",
      "details": "Pursuant to Regulation 30 of SEBI (LODR) Regulations 2015 read with Schedule III and in furtherance to our intimation date April 16 2026 and revised intimation dated April 17 2026 we are enclosing herewith the Notice of EGM of the Company scheduled to be held on Tuesday May 12 2026 at 12.30 PM (IST) through VC and OAVM. In compliance with the applicable circulars issued by MCA and SEBI the said EGM Notice along with the Explanatory Statement has been sent today through electronic mode only to those members whose email ID is registered with the Company / Depositories / RTA. The EGM Notice is also available on the Companys website at https://www.gennexlab.com. You are requested to kindly take the same on record.",
      "source": "BSE"
    },
    {
      "caption": "Board Meeting Outcome for Revised Outcome",
      "datetime": "17-Apr-2026",
      "details": "Revised outcome With reference to our earlier letter dated April 16 2026 in this connection we would like to submit the revised outcome of the Board Meeting as follows: 1. Convening of an Extraordinary General Meeting (EGM) of the Company on Tuesday May 12 2026 at 12:30 P.M through video conferencing/ other audio-visual means (VC/ OAVM) for the purpose of Regularization of Additional Director Ms. Khushbu Kachhawa (DIN: 10872432) as a Director (Non-Executive Independent Woman Director) of the Company; 2. Appointment of NSDL as authorized agency for facilitating EGM and providing E- Voting facility; 3. Appointment of Ms. Sweety Kapoor Practicing Company Secretary Kolkata as Scrutinizer for the EGM; 4. Fixation of E-voting period from May 08 2026 at 9.00 AM to May 11 2026 at 5.00 PM with cut-off date May 01 2026; A soft copy of the EGM Notice shall be sent in due course. We hereby submit that the Board Meeting had commenced at 04:00 PM and concluded at 04:30 PM.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "No <strong>Dividend</strong> history available",
      "data": []
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Gennex Laboratories Ltd has announced <strong>1:10</strong> stock split, ex-date: 14 Dec 09",
          "dt": "2009-12-14",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "",
      "data": [
        {
          "txt": "Gennex Laboratories Ltd has announced <strong>1:2</strong> rights issue, ex-date: 21 Jul 22",
          "dt": "2022-07-21",
          "middle_text": "Rights Issue"
        }
      ]
    }
  ]
}

News and Views

Gennex Laboratories Ltd is Rated Sell

2026-04-26 10:10:02

Gennex Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 26 April 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Gennex Laboratories Ltd is Rated Sell

2026-04-15 10:10:03

Gennex Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 15 April 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Gennex Laboratories Ltd: Valuation Shift Enhances Price Attractiveness Amid Mixed Returns

2026-04-06 08:01:15

Gennex Laboratories Ltd has witnessed a notable improvement in its valuation parameters, shifting from very attractive to attractive territory, driven primarily by a subdued price-to-earnings (P/E) ratio and price-to-book value (P/BV) metrics. Despite this positive valuation shift, the company’s stock performance over recent months and years presents a mixed picture when compared to broader market benchmarks such as the Sensex.

Read full news article

Gennex Laboratories Ltd is Rated Sell

2026-04-04 10:10:02

Gennex Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 Jan 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 04 April 2026, providing investors with the latest insights into its performance and outlook.

Read full news article

Five Consecutive Losses Push Gennex Laboratories Ltd to a New 52-Week Low

2026-03-30 14:21:21

Read full news article

Five Consecutive Losses Push Gennex Laboratories Ltd to a New 52-Week Low

2026-03-27 15:57:46

Read full news article

Markets Rally, But Gennex Laboratories Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off

2026-03-25 10:48:35

Despite a broad market upswing, Gennex Laboratories Ltd has slipped to a fresh 52-week low of Rs 8.06 on 25 Mar 2026, marking a near 53% decline from its 52-week high of Rs 17.25. This divergence from the market rally highlights persistent headwinds for the micro-cap pharmaceutical player.

Read full news article

Gennex Laboratories Ltd is Rated Sell

2026-03-24 10:10:02

Gennex Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 19 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 24 March 2026, providing investors with the latest insights into the company’s performance and outlook.

Read full news article

Markets Rally, But Gennex Laboratories Ltd Sinks to 52-Week Low in Stock-Specific Sell-Off

2026-03-23 12:36:11

Read full news article

View All News